“…Growth failure is considered a typical characteristic of infants affected by CdLS. Prenatal evidence shows that a reduced rate of growth can also be found during intrauterine life (Westergaard et al, ; Bruner and Hsia, ; Drolshagen et al, ; Cunniff et al, ; Jelsema et al, ; Kliewer et al, ; Pankau and Janig, ; Goolsby et al, ; Manouvrier et al, ; Ackerman and Gilbert‐Barness, ; Ranzini et al, ; Boog et al, ; Sekimoto et al, ; Huang and Porto, ; Marino et al, ; Hulinsky et al, ; Price et al, ; Le Vaillant et al, ; Lalatta et al, ; Chong et al, ; Sepulveda et al, ; Wilmink et al, ; Kanellopoulos et al, ; Akahori et al, ; Spaggiari et al, ): symmetrical intrauterine growth restriction has often been reported, with a trend of fetal abdominal and cephalic circumference that falls below the 10th percentile at approximately 25 weeks of gestation (Kliewer et al, ), but sometimes earlier, at 20 to 21 weeks of gestation (Boog et al, ; Sekimoto et al, ; Le Vaillant et al, ; Price et al, ) or even before the week 20 (Bruner and Hsai, ).…”